SBC Medical Group Holdings Inco (SBC) Stock Analysis
Recovery setup · Inst Constrain edge
Industrials · Consulting Services
Wait for pullback to $3.85. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $4.11. Engine's entry $3.85 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum.
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff... Read more
Wait for pullback to $3.85. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $4.11. Engine's entry $3.85 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: Death cross but MACD improving, RSI 75. V9 Gate blocked: Momentum 4.4 < 4.5 minimum; 50MA < 200MA with weak momentum (4.4) - hard block. Wait for improvement. Score 6.8/10, moderate confidence.
Passes 8/10 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 72d clear, semi cycle peak clear, materials cycle peak clear, sector concentration cap sector=industrials 0/10). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.
About SBC Medical Group Holdings Inco
About SBC Medical Group Holdings Inco
SBC Medical Group Holdings generated $173.6 million in revenue and $51.0 million in net income for fiscal 2025, down from $205.4 million in revenue a year earlier, almost entirely through management-service fees paid by 237 franchisee cosmetic and aesthetic-surgery clinics in Japan. The company also operates 21 clinics in Singapore and one in Vietnam, and closed its sole U.S. clinic in Irvine, California in May 2025.
SBC earns nearly all of its revenue from franchise management-service fees charged to medical corporations (MCs) that own and operate the clinics carrying its Shonan Beauty Clinic and other brand names — covering services such as advertising, staffing, booking, procurement, and IT and technology licensing. Since April 2025 the company has shifted to a tiered, performance-based fee structure keyed to each clinic's medical-service category, operational tenure, monthly revenue, and patient volume, plus a customer-loyalty point program that also generates revenue when reward points expire unredeemed. The franchisee base is concentrated: SBC's subsidiaries hold franchisor-franchisee or service contracts with only seven core medical corporations plus a handful of newer service-contract counterparties, and relatives of CEO Yoshiyuki Aikawa control two-thirds of the voting members at these MCs. The company has recently diversified geographically through the 2024 acquisition of Aesthetic Healthcare Holdings in Singapore, a July 2025 acquisition of MB career lounge in Japan, a December 2025 majority stake in Tokyo-listed Waqoo, and an 18.2% equity investment in the U.S.-based OrangeTwist network.
Show full overview
SBC's franchise structure is shaped by a regulatory constraint distinct from a typical Western franchisor: Japan's Medical Care Act bars non-physician entities from holding voting control over the medical corporations that own its clinics, so SBC Medical Sub holds only an equity interest, or mochibun, entitling it to a share of residual assets rather than board votes at the MCs' general meetings of members. That structure leaves clinic-level governance in the hands of related parties — relatives of CEO Yoshiyuki Aikawa control two-thirds of the voting members across the seven core MCs — a dependency the 10-K flags explicitly as a franchisee-concentration risk factor, separate from ordinary competitive pressure.
From SBC Medical Group Holdings Inco's most recent 10-K filing, extracted August 30, 2026.
Recent developments
updated 2026-08-31Recent Developments — SBC Medical Group Holdings Inco
Latest news
- NEWS SBC Medical Group at Q3 Investor Summit: growth re-accelerates By Investing.com - Investing.com Nigeria — Investing.com Nigeria positive
- NEWS SBC Medical Q2FY26 Results: Revenue up 13%, operating profit rises 30% - scanx.trade — scanx.trade positive
- NEWS Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holding — Yahoo Finance neutral
- NEWS Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price — marketscreener.com positive
Generated 2026-08-31T15:22:17Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $3.85. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $4.11. Engine's entry $3.85 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: Death cross but MACD improving, RSI 75. V9 Gate blocked: Momentum 4.4 < 4.5 minimum; 50MA < 200MA with weak momentum (4.4) - hard block. Wait for improvement. Target $7.44 (+81.0%), stop $3.36 (−22.3%), A.R:R 5.4:1. Score 6.8/10, moderate confidence.
Take-profit target: $7.44 (+81.0% upside). Target $7.44 (+81.0%), stop $3.36 (−22.3%), A.R:R 5.4:1. Stop-loss: $3.36.
SBC Medical Group Holdings Inco trades at a P/E of 8.4 (forward 7.5). TrendMatrix value score: 8.3/10. Verdict: Buy (Wait for Entry).
7 analysts cover SBC with a consensus score of 4.1/5. Average price target: $9.
What does SBC Medical Group Holdings Inco do?SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic...
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.